BAX vs TFX
BAX: Baxter International is a leading medical technology company delivering critical life-sustaining therapies for patients with complex medical conditions in hospitals and at home. TFX: Teleflex provides essential, specialty medical technologies used in critical care and surgical procedures to improve patient outcomes.
Side-by-side fundamentals
| Metric | BAX | TFX | Edge |
|---|---|---|---|
| Price as of 2026-08-21 close | $26.34 | $138.83 | |
| Market cap as of 2026-08-24 | $13.6B | $5.9B | |
| PEG as of 2026-08-24 | -0.02 | 0.74 | BAX lower |
| Net margin as of 2026-08-24 | -9.3% | -39.7% | BAX higher |
| Gross margin as of 2026-08-24 | +30.7% | +53.8% | TFX higher |
| Operating margin as of 2026-08-24 | -2.3% | -11.7% | BAX higher |
| ROE as of 2026-08-24 | -16.6% | -31.9% | BAX higher |
| ROA as of 2026-08-24 | -5.3% | -14.5% | BAX higher |
| Debt / equity as of 2026-08-24 | 1.52 | 0.97 | TFX lower |
| Revenue growth (YoY) as of 2026-08-24 | +5.4% | -14.5% | BAX higher |
| Revenue CAGR (3y) SEC XBRL | +3.8% | -10.6% | BAX higher |
| Dividend yield as of 2026-08-24 | +3.2% | +0.6% | BAX higher |
| Dividend streak (yrs) SEC XBRL | 1 | 5 | TFX higher |
| Beta as of 2026-08-24 | 0.65 | 0.81 | |
| 1-year return as of 2026-08-21 close | +10.4% | +11.4% | TFX higher |
Fundamentals: market data, as of 2026-08-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-21.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.